Welcome to our dedicated page for Phreesia news (Ticker: PHR), a resource for investors and traders seeking the latest updates and insights on Phreesia stock.
Phreesia, Inc. (NYSE: PHR) is a healthcare technology company focused on patient activation, digital intake, outreach and education for healthcare providers, life sciences companies and other organizations. The Phreesia news feed on Stock Titan highlights company announcements, financial updates and product developments that shape how it engages patients and supports healthcare workflows.
Investors and industry followers can use this page to review earnings releases and outlook updates, where Phreesia reports quarterly revenue, subscription and related services, payment processing fees, network solutions revenue and key metrics such as average healthcare services clients and revenue per client. These updates often include management commentary on operating leverage, cash flows and non-GAAP measures like Adjusted EBITDA.
The news stream also features transaction and financing disclosures, including details about the acquisition of AccessOne Parent Holdings, Inc., a provider of financing solutions for healthcare receivables, and related bridge loan and credit facility arrangements. These items are relevant for understanding Phreesia’s growth strategy and capital structure.
In addition, readers will find product and innovation news, such as the launch of Phreesia VoiceAI, an AI-driven phone solution for managing patient calls, and partnership and recognition stories, including the collaboration with Sesame Workshop and inclusion in rankings like the Deloitte Technology Fast 500™ and Capterra Shortlists. Bookmark this page to follow how Phreesia communicates its performance, platform enhancements and strategic initiatives over time.
Phreesia, Inc. (NYSE: PHR) reported fiscal fourth quarter and year results ending January 31, 2023, showcasing significant growth yet persistent net losses. Q4 revenue reached $76.6 million, a 32% increase YOY, with a total annual revenue of $280.9 million, also up 32%. The average number of healthcare services clients (AHSCs) grew 36% YOY to 3,140, though healthcare services revenue per AHSC fell 4%. A net loss of $38.0 million marks an improvement from $46.5 million last year. Despite cash reserves of $176.7 million, net losses expanded to $176.1 million for FY 2023. For FY 2024, Phreesia forecasts revenue between $353 million and $356 million.
Summary not available.
Phreesia has announced that Alexandra Beneville, Vice President of Life Sciences Content Strategy, has been named to MM+M's 2023 'Women to Watch' class, recognizing her as one of 18 influential women in the healthcare marketing field. Since joining Phreesia in August, Beneville has significantly impacted the company's Life Sciences strategy and operations, driving growth and enhancing diversity and inclusion. Phreesia, listed on the NYSE under the symbol PHR, focuses on empowering life sciences companies through tailored patient interactions and insights.
Summary not available.
Phreesia, Inc. (NYSE: PHR) will announce its fiscal fourth-quarter 2023 financial results on March 22, 2023, after market close. A press release detailing the results, along with a quarterly stakeholder letter, will be available on Phreesia's investor website. A conference call is scheduled for 5 PM ET the same day to discuss the results. Phreesia provides a comprehensive SaaS platform for healthcare organizations to improve patient intake processes, enhancing both patient experience and clinical efficiency.
Phreesia has collaborated with the Ad Council on three public health campaigns aimed at raising awareness among patients and caregivers regarding critical health issues. Since mid-2022, these campaigns have reached over half a million individuals, prompting significant engagement on topics such as pediatric COVID-19 vaccine safety, the risks of vaping, and high blood pressure control. The campaigns have demonstrated positive results, with increased likelihood of patients seeking information and discussing these health issues with their healthcare providers. The COVID-19 education initiative alone reached over 203,000 caregivers, with substantial interest in vaccination information.
Phreesia has been recognized for the second consecutive year by Medical Marketing and Media as one of the ‘Best Places to Work 2022’ in the healthcare marketing industry. The company, listed in the ‘Healthcare Service Providers’ category, is one of only three recognized. Phreesia’s inclusive culture, employee benefits, and professional growth opportunities were highlighted. Phreesia emphasizes hiring innovative employees and focuses on improving patient health outcomes. The company introduced several initiatives this year, including an employee recognition plan and a mentorship program, aimed at enhancing employee engagement and well-being.
Phreesia, Inc. (NYSE: PHR) reported Q3 2023 revenue of $73.1 million, a 31% increase from $55.9 million in Q3 2022. Average healthcare services clients rose by 42% to 2,982, but average revenue per client decreased by 9% to $17,645. The net loss widened to $40.2 million compared to $36.3 million a year earlier. Phreesia updated its FY 2023 revenue forecast to at least $278 million, reflecting 30% growth. Adjusted EBITDA outlook improved to negative $95 million. The company aims for $500 million in revenue by FY 2025 and anticipates achieving profitability in that year.
Phreesia has announced that Sara DiNardo, Vice President of Client Solutions, has been recognized as one of the Top 50 Women Leaders in SaaS of 2022 by The Software Report. This marks the fifth consecutive year a female leader from Phreesia has received such recognition, highlighting the company’s commitment to fostering leadership in the software industry. DiNardo oversees client services and success teams, aiming to enhance the patient experience within the healthcare technology sector.
Phreesia (NYSE: PHR) will release its fiscal Q3 2023 financial results on December 8, 2022, after market close. A press release will be available on ir.phreesia.com, along with a quarterly stakeholder letter. A conference call is scheduled for 5:00 PM ET on the same day to discuss the results. Phreesia provides a SaaS platform for healthcare organizations, improving patient intake and enhancing clinical care.
FAQ
What is the current stock price of Phreesia (PHR)?
What is the market cap of Phreesia (PHR)?
